Article Text

PDF
Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study
  1. A Gylling1,
  2. W M Abdel-Rahman1,
  3. M Juhola2,
  4. K Nuorva2,
  5. E Hautala1,
  6. H J Järvinen3,
  7. J-P Mecklin4,
  8. M Aarnio4,
  9. P Peltomäki1
  1. 1Department of Medical Genetics, University of Helsinki, Helsinki, Finland
  2. 2Department of Pathology, Jyväskylä Central Hospital, Jyväskylä, Finland
  3. 3Second Department of Surgery, Helsinki University Hospital, Helsinki, Finland
  4. 4Department of Surgery, Jyväskylä Central Hospital, Jyväskylä, Finland
  1. Correspondence to:
    Professor P Peltomäki
    Department of Medical Genetics, University of Helsinki, Biomedicum Helsinki, P O Box 63 (Haartmaninkatu 8), Helsinki 00014 Finland; paivi.peltomaki{at}helsinki.fi

Abstract

Background: Gastric cancer is the second most common extracolonic malignancy in individuals with hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome. As gastric cancer is relatively common in the general population as well, it is not clear whether or not gastric cancer is a true HNPCC spectrum malignancy.

Aim: To determine whether or not gastric cancer is a true HNPCC spectrum malignancy.

Subjects and methods: The molecular and clinicopathological profiles of gastric cancers (n = 13) from HNPCC mutation carriers were evaluated and compared with the profiles of sporadic gastric cancers (n = 46) stratified by histology and microsatellite instability (MSI) status.

Results: This study on sporadic and HNPCC gastric cancers revealed several important universal associations. Loss of heterozygosity in the adenomatous polyposis coli (APC) region was associated with intestinal histology regardless of the MSI (p = 0.007). KRAS-mutations (p = 0.019) and frameshift mutations in repeat tracts of growth-regulatory genes (p<0.001) were associated with MSI tumours being absent in microsatellite stable (MSS) tumours. The average number of methylated tumour suppressor gene loci among the 24 genes studied (methylation index) was higher in MSI than in MSS tumours regardless of histology (p<0.001). Gastric cancers from HNPCC mutation carriers resembled sporadic intestinal MSI gastric cancers, except that MLH1 promoter methylation was absent (p<0.001) and the general methylation index was lower (p = 0.038), suggesting similar, but not identical, developmental pathways. All these lacked the mismatch repair protein corresponding to the germline mutation and displayed high MSI.

Conclusion: The present molecular evidence, combined with the previous demonstration of an increased incidence relative to the general population, justify considering gastric cancers as true HNPCC spectrum malignancies.

  • APC, adenomatous polyposis coli
  • BRAF, B-Raf mutations
  • CIMP, CpG island methylator phenotype
  • HNPCC, hereditary non-polyposis colorectal cancer
  • IHC, immunohistochemistry
  • KRAS, K-ras mutation
  • LOH, loss of heterozygosity
  • MLPA, multiplex ligation-dependent probe amplification
  • MMR, DNA mismatch repair
  • MSI, microsatellite instability
  • MS-MLPA, methylation-specific MLPA
  • MSS, microsatellite stable
  • SNuPE, single nucleotide primer extension

Statistics from Altmetric.com

Footnotes

  • Published Online First 31 January 2007

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    BMJ Publishing Group Ltd and British Society of Gastroenterology